GEODE CAPITAL MANAGEMENT, LLC - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$23,810,896
-20.9%
1,186,837
+11.2%
0.00%
-25.0%
Q2 2023$30,117,033
+95.4%
1,067,601
+19.2%
0.00%
+100.0%
Q1 2023$15,409,916
+89160.4%
895,925
+4.5%
0.00%0.0%
Q4 2022$17,264
-99.9%
857,217
+2.5%
0.00%
-33.3%
Q3 2022$18,112,000
-17.5%
836,210
+7.0%
0.00%0.0%
Q2 2022$21,958,000
-28.6%
781,444
+17.3%
0.00%
-25.0%
Q1 2022$30,732,000
-44.7%
666,064
+0.7%
0.00%
-42.9%
Q4 2021$55,581,000
+29.8%
661,211
+2.9%
0.01%
+16.7%
Q3 2021$42,826,000
+81.4%
642,654
+44.8%
0.01%
+100.0%
Q2 2021$23,608,000
+48.3%
443,765
+21.0%
0.00%
+50.0%
Q1 2021$15,917,000
-7.6%
366,840
+10.6%
0.00%
-33.3%
Q4 2020$17,233,000
+190.6%
331,789
+82.9%
0.00%
+200.0%
Q3 2020$5,931,000
-23.9%
181,447
+11.8%
0.00%
-50.0%
Q2 2020$7,795,000162,3350.00%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,426,095$111,940,0006.63%
Paradigm Biocapital Advisors LP 287,577$13,269,0003.51%
Avidity Partners Management LP 3,176,999$146,587,0003.05%
Integral Health Asset Management, LLC 215,000$9,920,0002.58%
Matrix Capital Management Company, LP 4,349,279$200,676,0002.41%
Affinity Asset Advisors, LLC 207,500$9,574,0001.53%
Ikarian Capital, LLC 202,203$9,329,0001.23%
Ghost Tree Capital, LLC 80,000$3,691,0000.80%
Eventide Asset Management 761,000$35,113,0000.55%
Perceptive Advisors 501,509$23,140,0000.46%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders